AzTrials
AzTrials

Breast CancerPW2NCT04259905

Pink Warrior 2: Teleconference-based Gaming Support

A study testing Active video game teleconference support group and Standard support group + pedometer in people with Breast Cancer and Physical Activity, run by The University of Texas Medical Branch, Galveston at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Breast cancer survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decrease of physical activity immediately after diagnosis. Read more about this study

Who is it for?
Ages 55 to 79 years, women only
Conditions the study is for
Breast Cancer, Physical Activity
What is being tested?
Active video game teleconference support group and Standard support group + pedometer
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
2 sitesUnited States
Study dates
11 May 2020to 29 Mar 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 79 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Provide informed consent
  • Diagnosed with primary female breast cancer
  • 55 years to 79
  • Able to speak, read, and write in English
  • Able to travel to UTMB locations and/or MD Anderson Victory Lakes
  • Able to move arms and les as well as ambulate
  • Has a smartphone, tablet or computer and daily access to a reliable internet

Who cannot join

  • Pregnancy
  • Diagnosed dementia
  • Currently engage in 150 minutes or more of planned moderate intensity physical activity
  • Currently involved in another physical activity intervention

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • The University of Texas Medical Branch

    Galveston, Texas, 77555

  • UT MD Anderson Cancer Center

    Houston, Texas, 77054

Other trials in United States

About this study

Official title: Pink Warrior 2.0: Teleconference Support Group Toolkit for Breast Cancer Survivors

Breast cancer survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decrease of physical activity immediately after diagnosis. Despite the known benefits of physical activity-speeding recovery time and reduced cancer recurrence risk-only 1 in 3 survivors met physical activity recommendations of 150 minutes of moderate-intensity activity per week. Physical activity interventions have shown effectiveness in helping breast cancer survivors increase physical activity during treatment, but limited evidence-based physical activity interventions have been incorporated into the clinic and community. To address this limitation, the investigators are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior.

The goal of this study is to compare an intervention that uses active games versus an intervention uses pedometer to encourage physical activity such as walking within breast cancer survivors in active cancer treatment. The study will include breast cancer survivor between the ages of 18 - 70 whom currently gets less than 150 minutes of planned physical activity per week and received a breast cancer diagnosis within 0 to 6 months. Participants will be randomized to participate in the support group using the active video game-based physical activity intervention (Wii and Xbox active games) or to participate in the existing UTMB breast cancer support group with pedometers (Digi-Walker CW-700/701). The investigators hypothesize that by engaging in active video gaming, breast cancer survivors will be motivated to initiate and maintain physical activity during treatment. This will ultimately increase functional capacity and prevent functional disability in breast cancer survivors.

Read the detailed description

Increasing and maintaining physical activity among female breast cancer (BC) survivors during treatment remains an unresolved problem in BC survivorship care. BC survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decline of physical activity immediately after diagnosis. Despite the known benefits of physical activity-speeding recovery time and reduced cancer recurrence risk-less than 30% of survivors met physical activity recommendations. Physical activity interventions have shown effectiveness in helping BC survivors increase activity during treatment, but limited evidence-based activity interventions have been disseminated into the clinic and community. To address this limitation, we are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior, which will investigate the feasibility of implementing active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Participants (N = 60) will be randomized to participate in the support group using the active video game-based physical activity intervention or to participate in the existing UTMB breast cancer support group with pedometers. Our specific aims are:

Aim 1: Evaluate the feasibility and acceptability of active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Measures of feasibility will include weekly attendance records, number of completed home-based worksheets, number of participants completing the program activities, technological issues, and adverse events.

Aim 2: Compare the support group using the active video game-based physical activity intervention to the existing UTMB breast cancer support group with pedometer. Primary outcomes will be changes in physical activity. Secondary outcomes will be changes in physical function, dietary pattern, and quality of life.

Aim 3: Develop tools for implementation of the Pink Warrior intervention within the clinic and community settings. A trainer's manual for the Pink Warrior intervention will be developed and UTMB Breast Cancer Support Group facilitators will be trained by research staff to implement the program.

Being tested
Active video game teleconference support group, Standard support group + pedometer
Keywords
active video game, telemedicine, cancer survivor, women's health, support group, survivorship, mhealth
Medical subject headings
Breast Neoplasms, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active video game teleconference support groupBehavioural

    12 sessions of teleconferenced support group meetings, including active video game play + self-paced walking monitored by Fitbit wearable device

  • Standard support group + pedometerBehavioural

    3 monthly sessions of in-person standard support group meetings + self-paced walking monitored by pedometer

Study groups in NCT04259905
Study groupRoleWhat they receive
Active video game teleconference support groupExperimentalParticipants will attend enhanced support group meetings via zoom teleconferencing software. Support group meetings will include group play of active video games and discussion of survivorship topics. Participants will self-monitor physical activity using Fitbit wearable activity monitors and will receive a water bottle and tote bag.
Receives: Behavioral: Active video game teleconference support group
Standard support group + pedometerActive comparatorParticipants will attend standard in-person support groups currently offered by the UTMB Breast Health Center. They will also receive a standard pedometer and a water bottle and tote bag.
Receives: Behavioral: Standard support group + pedometer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Walking Physical Activity as Measured by Change in Daily Steps From Baseline to 14 Weeks

    Difference in mean of daily steps taken from Actigraph accelerometer worn for 7 day period from baseline assessment to 14 week assessment

    Measured: Baseline to 14 weeks

Secondary outcomes (2)
  1. Quality of Life as Measured by the Change in FACT-B Scores From Baseline to 14 Weeks

    Quality of life score as measured by the Functional Assessment of Cancer Therapy-Breast measure at follow-up, scored for physical, social, emotional, functional, and breast well-being (here we report the total score of these subscales). The range for this scale is 0-123, with 0 indicating a better outcome.

    Measured: Baseline to 14 weeks

  2. Physical Performance as Measured by the Change in Short Physical Performance Battery Scores From Baseline to 14 Weeks

    Difference in physical performance as measured by Short Physical Performance Battery from baseline to 14 weeks. The numbers reported here are the sum of scores from the subscales. The range for this measure is between 0-12, with lower scores indicating better outcomes.

    Measured: Baseline to 14 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2020
  2. Study start11 May 2020
  3. Primary completion29 Jan 2022
  4. Study completion29 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04259905
Sponsor's protocol ID
16-0040-02
Other IDs
5P30AG024832
Acronym
PW2
Status last verified
May 2023
First submitted
30 Jan 2020
Last updated
8 Jun 2023
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Active video game teleconference support group and Standard support group + pedometer in people with Breast Cancer and Physical Activity, run by The University of Texas Medical Branch, Galveston at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 8 Jun 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Walking Physical Activity as Measured by Change in Daily Steps From Baseline to 14 Weeks (time frame: Baseline to 14 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in